Envista's and welcome earning call. first Thanks, everyone John, to
as public progress pleased the has the and began We completed building XXXX, margins are XXXX quarter a York of exceeded listed our the team consolidation, cost IPO and New Envista. resulting In in Envista company. milestone of our process initiatives have in made flow first since made traction The our reinvesting on simplification and with journey in business. event we We our several September to expectations. earning, the results this cash Exchange. Stock This in that tremendous another and transform now marked in
associates, thank several like as months as the to for make dedication well happen. support like stand work also many to employees way. would would our the past own and I hard our Danaher along the thank to this their on help to XX,XXX from I over opportunity us the Danaher for who
orthodontics describing as and in as minutes implants include in a billion $X.X consumables would business. dental company Envista our details, our traditional I into global moving like technologies, revenue spend and priorities. Envista, and our the specialty is products well and purpose a equipment to leading which Before a few annual and positions with
that champion. professionals imaging, composed need goals, To Envista, attractive with do create margins. a We to our profit purpose more to specialty their They consumables At beautiful creating is smiles. Over confidence. know which they XX% is have healthy and of partner than professionals and generally growth achieve dental improve of portfolio lives. our rates
them. We serve, deep improvement for for services toward to Envista, uniquely buy professionals. will innovative their action, champion. be combination that we A respect partner there dental we’re us product professionals in be At a positioned and with involved of us continuous to
aesthetics general Our as dental human its comprehensive as practitioners treat product conditions portfolio smile. specialties enables to well diagnose, and and prevent the improving of
as strengthening priorities our improvement. for continuous margin accelerating portfolio and System, focused or addition, In Envista our expanding around EVS, growth, Business our with are guide
Our have and clear We innovations growth or commercial and such accelerate orthodontic been investment markets impact rate in emerging aligners, workflows. in the high will high improve of as dental our implants over these our tools EVS our execution to areas digital growth the growth and growth time. cadence improve innovation anticipate
to already and the work this You're starting our of business. see in impact orthodontic China in
since Executing and XXXX, innovation towards and on brands which These reinvested more organization, EVS have helping to and us savings facilities. cost we lead commercial than in have principles simplify our consolidate $XX million is resources. actions yielded
expand specialty we next the years, additional productivity savings product meaningful cost growth million and there businesses Over savings. are accelerated opportunity a further as remains rates targeting margins to believe higher in $XX We in three are margin realized. in
us Finally, agility inorganically. public separate gives being to transform a our company the portfolio
enhance cash through and us positions provide Our strong the strategic M&A. to balance our sheet flow flexibility
have making senior team to Danaher have addition particularly board, on at strategic to and strong experiences. Envista, who M&A our we and fortunate extensive In a executives are deal
business. to adjusted Core Sales let's acquisitions from Now decreased third impact growth discontinued and to quarter. in primarily currency, to our million. transformation X% the the due core our equipment divestiture growth X.X% and value products. business $XXX and demand for turn in declined is in lower performance implant Envista’s our
China than X.X% within businesses. quarter, X% from products and at impacted from the In growth weaker has for foreign grown market revenue debit-digit adversely rate with single This million. particularly to full anticipated and rates $XXX story discontinued conditions in third further double-digit growth of equipment rate another by at decreased a and revenue excess Geographically, Envista. primarily currency. was has offset our market been annualized has developed now for consumable which digit success of was quarter China, consecutive low
expand tremendous core which to opportunity Gross traction continued points decrease due points not to capacity margin as in Envista’s continue in investment XX a to XX.X% but also is spending our there basis emerging margin China, the rate. revenue building. XX.X% in in XX enhance growth believe gain declined to We and to Operating revenue future moderated. basis market, core savings profit initiatives other decreased and only
in the Our quarter a million, flow was comparable free cash XX% for the over $XX period XXXX. third increase
the Envista and flow us net for the modest was cash our ratio free cash levels ample provide XXX%. strategy. debt conversion to earnings Our flow, to with pursue This capacity significant priority M&A
was adjusted quarter net Third non-GAAP EPS diluted which expectations. our exceeded $X.XX,
segments. Turning now our to two business
during and mid of by our improvement rate within grown improved execution. commercial to our segment technologies business Biocare due cost XXX orthodontic implant first our single-digit Systems. business, during points business. Ormco, products quarters at strong and X.X%. three Nobel of to the products Operating Ormco and revenues basis margin were the Segment a strong profit continued cadence increased steady implant a and quarter revenues driven specialty Our XX.X%, core margin to new flat has demand includes experience XXXX, reduction, while largely
XX%. adoption the quarter rate like Payment generation which the systems by of revenues next at increased in of a by system, has DQX double-digit over increased
force product. material with using Spark, the to The the attachments crowding Spark can software retention. also excited allows range a used to about and aligner treat growth accelerate easily The stain of spacing. material. movement software system, and further advanced orthodontists Ormco's problems are Spark make scale flexible ability unique advanced such and TruGEN full We is tooth a minimize Spark as visualize to transplant address delivers common that the malocclusions
to our expansion of are After phase with revenue noticeable on expand effective, to be our orthodontists core doctors focused and the XXXX a contributor clear we that our aligner combination as Spark case in launch to of Australia new our of capacity. orthodontic year, part process provide We anticipate an business a would comfortable less helps and clear customers. more in This proprietary U.S. onboard more successful in previewed meaningful patients in as group manufacturing last us solution. aligner continue a plan
slightly within China. implant brands as value and implant growth improved was our a well U.S. in increased process the outside consolidating transformation Our of business the business by
by this rationalization to of anticipate brand value largely complete end XXXX. the be We
As treatment traditional we challenging and patient have and said, techniques innovation, toward Nobel has the made Biocare tremendous progress paving for centric solutions. way team practitioner
OsseoShaper faster less it techniques clinicians like should two speed feeding the supports the the ultimately instrument, that NX in patented with highlighted to system implant lower During in grows of we And prosthetic patients quarter, easier to and planning treat workflow discomfort Lisbon. allow for that delivery. Association which time we patients. believe system European to is from use resolve the new NX Osseointegration it complete implant a at
growth the provide opportunity about our one implant excited and portfolio. would were We
XXX developed This the Our consumables. revenue operating was Covell margins equipment care partially business as a office and and in traditional led to brand basis decrease end markets. equipment digit our by largely equipment decreased single in portfolio low consumables, broad general weakened services Equipment declined demand dental and of and down by due revenue. our product to X% growth and customer in profit business. the consumables offset X.X% imaging, around revenues Reported and consumable segment were core anchored offers points X.X%, within
XXXX. with our made transformation footprint of expansion returns improvement, tremendous reducing sizing our cost rationalizing grow manufacturing and cost we’re as The business our the have our quarter to As results as reducing and first our brands. in public focused drive company. part pleased team of right process, to a products structure, portfolio we closing, further on remains margin In our
cost exceeded earnings, on has team flow a traction our expectations. in made of margins resolved and cash initiatives number that Our
separate improving areas priorities implant and accelerating by transforming a and as emerging as our journey margins high investing such centered strategic markets, our around in growth portfolio. impact our begin we As clear company, are aligners,
years made you over the look updating progress good enhanced have past and as performance business several move through to forward. we forward We
$X.XX This the adjusted $X.XX between be diluted recent down quarter We quarter will fourth and diluted weaker non-GAAP equipment demand. anticipates core $X.XX. that between were and single-digits EPS guidance EPS net growth fourth GAAP guidance reflecting low initiating $X.XX and
diluted year, we and of and non-GAAP $X.XX. excited the a be net $X.XX to our in begin feel between For we Envista. as ready, about diluted as journey EPS range energized EPS company. at separate public We're anticipate net to $X.XX prospects our full adjusted We the $X.XX